Mr. Bill Morachnick reports

CHARLOTTE'S WEB APPLAUDS CONGRESSIONAL ACTION TO ADVANCE CONTINUING RESOLUTION

Charlotte's Web Holdings Inc. today welcomed the U.S. House of Representatives' passage of the continuing resolution (CR), which was approved by a vote of 370-48, following the Senate's earlier passage of the measure. The legislation will now be sent to the president for signature and enactment into law.

The passage of the CR helps ensure continuity of government operations while providing additional time until Dec. 11, 2026, for Congress to complete work on longer-term policy priorities. This measure delays the Nov. 12 ban on naturally derived hemp products while maintaining the prohibition on synthetic cannabinoids.

"Charlotte's Web appreciates the House's action to advance this legislation and give Congress time to develop thoughtful regulation that separates naturally derived, therapeutic products from intoxicating synthetics and high-THC products," said Bill Morachnick, chief executive officer of Charlotte's Web. "Regulatory certainty is critical for businesses, consumers, farmers and stakeholders across the hemp industry. We are encouraged to see lawmakers come together to advance an opportunity for the broader policy discussions to continue."

As the nation's leading hemp CBD wellness company, Charlotte's Web remains committed to advocating for science-based regulations, and a clear federal framework that protects consumers, supports responsible businesses and enables continued innovation across the hemp-derived product marketplace.

Mr. Morachnick added: "The future of therapeutic hemp should not be defined by the highest-risk products in the category. It should be defined by consumer safety, product integrity and science. We believe lawmakers can deliver a framework that protects Americans while preserving access to the wellness products that have helped so many people improve their quality of life."

About Charlotte's Web Holdings Inc.

Charlotte's Web Holdings, a certified B corporation headquartered in Louisville, Colo., is a botanical wellness innovation company and a market leader in hemp extract wellness that includes Charlotte's Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD and cannabinoid isolates. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf. Shares of Charlotte's Web trade on the TSX under the symbol CWEB and are quoted in U.S. dollars in the United States on the OTCQX under the symbol CWBHF.

We seek Safe Harbor.